Stock listing
Xetra:FYB Formycon AG Aktie
Home listing (Xetra) of Formycon AG
Follow Formycon AG into a list and get an email when it puts out news.
Share price · XETR:FYB
€20.25 EUR -1.25 (-5.8%)
Close on Oct 14, 2026

- Ticker
- Xetra:FYB
- Asset type
- Stock
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Oct 13, 2026
Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 18 slides
Latest news
Decks
Investor Presentation (September 2026)
Investor deck · 18 slides · September 2026
Investor Presentation (May 2026)
Investor deck · 18 slides · May 19, 2026
Investor Presentation (April 2026)
Investor deck · 18 slides · April 2026
Investor Presentation (November 2025)
Investor deck · 19 slides · November 2025
Formycon AG on 6ix
- News releases
- 25 in the last 12 months · 29 in all · newest Oct 13, 2026 · oldest 2025
- Decks
- 21 decks · latest September 2026
Where Formycon AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Xetra:FYB · Home listing · This page | Xetra | Germany | EUR |
| gettex:FYB | gettex | Germany | EUR |
| Tradegate:FYB | Tradegate | Germany | EUR |
| LSE:0W4N | LSE | United Kingdom | EUR |
| LS Exchange:A1EWVY | LS Exchange | Germany | EUR |
| Stuttgart:FYB | Stuttgart | Germany | EUR |
| Frankfurt:FYB | Frankfurt | Germany | EUR |
| Lang & Schwarz:A1EWVY | Lang & Schwarz | Germany | EUR |
| Aquis:FYBD | Aquis | United Kingdom | EUR |
| Munich:FYB | Munich | Germany | EUR |
| Dusseldorf:FYB | Dusseldorf | Germany | EUR |
| Hamburg:FYB | Hamburg | Germany | EUR |
| Hanover:FYB | Hanover | Germany | EUR |
| Aquis:FYBD | Aquis | United Kingdom | EUR |
| BX Swiss:FYB | BX Swiss | Switzerland | CHF |
| BX Swiss:FYBEUR | BX Swiss | Switzerland | EUR |
| OTC:FYBGF | OTC | United States | USD |
| Turquoise:FYBD | Turquoise | United Kingdom | EUR |
| VIE:FYB | Vienna | Austria | EUR |
Log in to ask 6ix AI your own questions about Formycon AG.